Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer

Journal of Urology

Volumn 171, Issue 4, 2004, Pages 1461-1466

  Okegawa, Takatsugu ^a   Kinjo, Manami ^a   Nutahara, Kikuo ^a   Higashihara, Eiji ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Keratin; Polymerase chain reaction; Prognosis

Indexed keywords

CISPLATIN; CYTOKERATIN 20; DOXORUBICIN; METHOTREXATE; UROPLAKIN; VINBLASTINE SULFATE;

ADULT; ARTICLE; BLADDER BIOPSY; BLOOD; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL SEPARATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UROGENITAL TRACT TUMOR;

EID: 1642364075     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000118648.29024.b7     Document Type: Article

References (20)

1. Van der Meijden, A. P. M.: Bladder cancer. Br Med J, 317: 1366, 1988
2. Ghossein, R. A., Bhattacharya, S. and Rosai, J.: Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res, 5: 1950, 1999
3. Pantel, K. and von Knebel Doeberitz, M.: Detection and clinical relevance of micrometastatic cancer cells. Curr Opin Oncol, 12: 95, 2000
4. Mellado, B., Gutierrez, L., Castel, T., Colomer, D., Fontanillas, M., Castro, J. et al: Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients. Clin Cancer Res, 5: 1843, 1999
5. Wharton, R. Q., Jonas, S. K., Glover, C., Khan, Z. A., Klokouzas, A., Quinn, H. et al: Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Clin Cancer Res, 5: 4158, 1999
6. Leitzel, K., Lieu, B., Curley, E., Smith, J., Chinchilli, V., Rychlik, W. et al: Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription-polymerase chain reaction for epidermal growth factor receptor. Clin Cancer Res, 4: 3037, 1998
7. Okegawa, T., Nutahara, K. and Higashihara, E.: Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer. J Urol, 163: 1183, 2000
8. Okegawa, T., Noda, H., Kato, M., Miyata, A., Nutahara, K. and Higashihara, E.: Value of reverse transcription polymerase chain reaction assay in pathological stage T3N0 prostate cancer. Prostate, 44: 210, 2000
9. Wu, X. R., Lin, J. H., Walz, T., Haner, M., Yu, J., Aebi, U. et al: Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins. J Biol Chem, 269: 13716, 1994
10. Yu, J., Lin, J. H., Wu, X. R. and Sun, T. T.: Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins. J Cell Biol, 125: 171, 1994
11. Li, S. M., Zhang, Z.-T., Chan, S., McLenan, O., Dixon, C., Taneja, S. et al: Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder. J Urol, 162: 931, 1999
12. Lu, J. J., Kakehi, Y., Takahashi, T., Wu, X. X., Yuasa, T., Yoshiki, T. et al: Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer. Clin Cancer Res, 6: 3166, 2000
13. Golijanin, D., Shapiro, A. and Pode, D.: Immunostaining of cytokeratin 20 in cells from voided urine for detection of bladder cancer. J Urol, 164: 1922, 2000
14. Inoue, T., Nakanishi, H., Inada, K.-I., Hioki, T., Tatematsu, M. and Sugimura, Y.: Real time reverse transcriptase polymerase chain reaction of urinary cytokeratin 20 detects transitional cell carcinoma cells. J Urol, 166: 2134, 2001
15. Moll, R., Lowe, A., Laufer, J. and Franke, W. W.: Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol, 140: 427, 1992
16. Southgate, J., Hutton, K. A., Thomas, D. F. and Trejdosiewicz, L. K.: Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab Invest, 71: 583, 1994
17. Fujii, Y., Kageyama, Y., Kawakami, S., Kihara, K. and Oshima, H.: Detection of disseminated urothelial cancer cells in peripheral venous blood by a cytokeratin 20-specific nested reverse transcriptase-polymerase chain reaction. Jpn J Cancer Res, 90: 753, 1999
18. Güdemann, C. J., Weitz, J., Kienle, P., Lacroix, J., Wiesel, M. J., Soder, M. et al: Detection of hematogenous micrometastasis in patients with transitional cell carcinoma. J Urol, 164: 532, 2000
19. Sobin, L. H. and Wittekind, Ch.: UICC: TNM Classification of Malignant Tumours, 5th ed. New York: Wiley-Liss, pp. 185-190, 1997
20. Gazzaniga, P., Gandini, O., Giuliani, L., Magnanti, M., Gradilone, A., Silvestri, I. et al: Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients. Clin Cancer Res, 7: 577, 2001